MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
1.02E4 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
1.01E4 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
CD2AP |
CD2AP: CD2-associated protein |
1.01E4 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
9.90E3 |
Evidence |
|
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
9.88E3 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
9.88E3 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
9.88E3 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
9.88E3 |
Evidence |
|
INHBA |
INHBA: Inhibin beta A chain precursor |
ACVR2A |
ACVR2A, ACVR2: Activin receptor type-2A precursor |
9.69E3 |
Evidence |
O
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
9.58E3 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
9.49E3 |
Evidence |
O
|
HCK |
IPI00029769 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
9.29E3 |
Evidence |
O
|
HDAC2 |
HDAC2: Histone deacetylase 2 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
9.29E3 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
9.26E3 |
Evidence |
|
SNRPF |
SNRPF, PBSCF: Small nuclear ribonucleoprotein F |
SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
9.11E3 |
Evidence |
O
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
9.10E3 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
JUND |
JUND: Transcription factor jun-D |
9.10E3 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
8.91E3 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
8.91E3 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
8.73E3 |
Evidence |
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
8.72E3 |
Evidence |
|
VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
VTI1A |
VTI1A: Vesicle transport through interaction with t-SNAREs homolog 1A |
8.72E3 |
Evidence |
|
EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
8.70E3 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
8.68E3 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
8.52E3 |
Evidence |
|